BAMS
IONS icon

Bellevue Asset Management (Switzerland)’s Ionis Pharmaceuticals IONS Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$8.55M Buy
138,000
+6,000
+5% +$324K 1.3% 23
2015
Q3 		$5.33M Buy
132,000
+10,000
+8% +$518K 0.87% 41
2015
Q2 		$7.02M Sell
122,000
-25,000
-17% -$1.59M 0.97% 36
2015
Q1 		$9.36M Buy
+147,000
New +$9.97M 1.31% 26

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s IONS Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Ionis Pharmaceuticals (IONS) stake by 4.5% in Q4 2015, buying an estimated $324K and bringing the position to 138,000 shares worth $8.55M. The position accounts for 1.3% of the portfolio, ranked #23.

Bellevue Asset Management (Switzerland) first reported a position in IONS in Q1 2015 and has held it in 4 quarters since. The position peaked at $9.36M in Q1 2015. 335 funds tracked by Wall St. Rank hold IONS as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 138,000 shares of Ionis Pharmaceuticals worth $8.55M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 6,000 Ionis Pharmaceuticals shares in Q4 2015, an estimated $324K.
  • Ionis Pharmaceuticals made up 1.3% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #23 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Ionis Pharmaceuticals position peaked at $9.36M in Q1 2015.
  • 335 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.